Seems you have not registered as a member of localhost.saystem.shop!
You may have to register before you can download all our books and magazines, click the sign up button below to create a free account.
China Goes Green
What does it mean for the future of the planet when one of the world’s most durable authoritarian governance systems pursues “ecological civilization”? Despite its staggering pollution and colossal appetite for resources, China exemplifies a model of state-led environmentalism which concentrates decisive political, economic, and epistemic power under centralized leadership. On the face of it, China seems to embody hope for a radical new approach to environmental governance. In this thought-provoking book, Yifei Li and Judith Shapiro probe the concrete mechanisms of China’s coercive environmentalism to show how ‘going green’ helps the state to further other agendas such as citizen...
Entrepreneurial and Business Elites of China
This important reference title provides comprehensive, up-to-date coverage of elite entrepreneurs of new China and contains over 100 substantial profiles of top overseas returnees who have made noteworthy contributions to Chinese society in general and economic development in particular since the reform era began in 1978.
Global Sustainable Cities
Perspectives from worldwide experts on how major cities across the globe are responding to the major environmental threats of our time, including global climate change Over half of the world’s population now lives in cities, and this share is expected to increase in the coming decades. With growing urbanization, cities and their residents face substantial environmental challenges such as higher temperatures, droughts, wildfires, and increased flooding. In response to these pressing challenges, some cities have begun to develop local environmental regulations that supplement national and environmental laws. In so doing, cities have stepped into a role that has been historically dominated by...
Case Reports in General Cardiovascular Medicine: 2023
This Research Topic aims to collect all case reports submitted to structural interventional cardiology section. All the case reports submitted to this collection will be assessed by a senior Associate Editor before beginning the peer review process. Please make sure your article adheres to the following guidelines before submitting. Case reports highlight unique cases of patients that present with an unexpected diagnosis, treatment outcome, or clinical course. Only case reports that are original and significantly advance the field will be considered: 1) RARE case with TYPICAL features 2) FREQUENT case with TYPICAL features 3) Cases with a convincing response to new treatments Case report for...
Inflammatory factors in coronary heart disease: Mechanism, diagnosis and therapy
description not available right now.
Metabolic Regulation in the Development of Cardiovascular Diseases
description not available right now.
Navigating the Polycrisis
An innovative work of realism and utopianism that analyzes the possible futures of the world-system and helps us imagine how we might transition beyond capitalism. The world-system of which we are all a part faces multiple calamities: climate change and mass extinction, the economic and existential threat of AI, the chilling rise of far-right populism, and the invasion of Ukraine, to name only a few. In Navigating the Polycrisis, Michael Albert seeks to illuminate how the “planetary polycrisis” will disrupt the global community in the coming decades and how we can best meet these challenges. Albert argues that we must devote more attention to the study of possible futures and adopt trans...
Community Series in Novel Biomarkers for Predicting Response to Cancer Immunotherapy, volume II
This Research Topic is the second volume of the “Community Series in Novel Biomarkers for Predicting Response to Cancer Immunotherapy". Please see Volume I here. Immunotherapy has revolutionized the treatment of malignancies. Targeting of immune checkpoints cytotoxic T-lymphocyte-associated protein 4, programmed cell death protein 1 (PD-1) and its ligand (PD-L1) has led to improving survival in a subset of patients. Despite their remarkable success, clinical benefit remains limited to only a subset of patients. A significant limitation behind these current treatment modalities is an irregularity in clinical response, which is especially pronounced among checkpoint inhibition. Currently, re...
